美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医药外包概念

1,816.34

+11.510.64%

涨家数：1

跌家数：1

平家数：1

市盈率：- -

高：1,817.70

开：1,796.57

低：1,783.76

收：1,804.83

成交量：35.51万

成交额：6,684.27万

市值：460.09亿

流通市值：440.13亿

数据加载中...

总览新闻资讯

查尔斯河实验室的调查涉及请求提供有关非人灵长类动物来源及相关披露的信息

查尔斯河实验室国际公司 - SEC结束调查，不对查尔斯河实验室采取行动 - SEC备案

查尔斯河实验室国际公司：Baird 将评级上调至“跑赢大盘”；目标价从178美元上调至199美元

查尔斯河高管表示，预计2025年制造收入将在有机基础上持平至略微下降，较之前的预计基本持平有所调整

查尔斯河高管表示，尚未受到NIH预算不确定性或政府停摆的重大影响

查尔斯河高管表示，许多全球生物制药客户似乎已在重组工作中取得进展，生物科技融资环境在第三季度表现出改善迹象

查尔斯河实验室高管表示将努力在2026年中期前完成潜在的资产剥离

查尔斯河公司计划出售表现不佳的资产，加大成本削减力度

查尔斯河实验室国际公司 - 2026年前每年额外节省7000万美元的举措

查尔斯河实验室国际公司：预计将出售部分表现不佳或非核心业务

Lisata Therapeutics 强调 Certepetide 作为抗体药物偶联物组合的积极前临床数据

诺和诺德工厂出纰漏，再生元遭发CRL

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4530/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"医药外包概念","latestPrice":1816.3418,"timestamp":1763393851473,"preClose":1804.8273,"halted":0,"volume":355101,"delay":0,"changeRate":0.00638,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":11.514526,"latestTime":"11-17 10:37:32 EST","open":1796.5658,"high":1817.7023,"low":1783.7587,"amount":66842718.45684,"amplitude":0.018807,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.850616,"peRate":38.642013,"turnoverRate":0.001679,"increases":1,"decrements":1,"flats":0,"marketCap":46008554496,"floatMarketCap":44013330944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":1817.7023,"amplitude":0.018807,"preClose":1804.8273,"low":1783.7587,"pbRate":"4.850616","latestPrice":1816.3418,"volume":355101,"delay":0,"open":1796.5658,"prevYearClose":1673.3123,"prevWeekClose":1804.8273,"prevMonthClose":1800.054,"prevQuarterClose":1576.7454,"fiveDayClose":1756.5254,"twentyDayClose":1778.77,"sixtyDayClose":1595.649,"secType":"PLATE","market":"US","turnoverRate":0.001679,"peRate":38.642013,"marketCap":46008554496,"floatMarketCap":44013330944,"timestamp":1763393851473,"nameCN":"医药外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":1,"down":1,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199937964","title":"查尔斯河实验室的调查涉及请求提供有关非人灵长类动物来源及相关披露的信息","url":"https://stock-news.laohu8.com/highlight/detail?id=1199937964","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199937964?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 21:11","pubTimestamp":1763385085,"startTime":"0","endTime":"0","summary":"查尔斯河实验室的调查涉及请求提供有关非人灵长类动物来源及相关披露的信息","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","IE00BFMHRM44.USD","BK4121","BK4588","LU0757428866.USD","LU1815336091.USD","CRL","BK4530","BK4585"],"gpt_icon":0},{"id":"1125272874","title":"查尔斯河实验室国际公司 - SEC结束调查，不对查尔斯河实验室采取行动 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1125272874","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125272874?lang=zh_cn&edition=fundamental","pubTime":"2025-11-17 21:08","pubTimestamp":1763384893,"startTime":"0","endTime":"0","summary":"查尔斯河实验室国际公司 - SEC结束调查，不对查尔斯河实验室采取行动 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL","LU0757428866.USD","LU0390134368.USD","BK4588","BK4530","IE00BFMHRM44.USD","LU1815336091.USD","BK4121","BK4585"],"gpt_icon":0},{"id":"1130402864","title":"查尔斯河实验室国际公司：Baird 将评级上调至“跑赢大盘”；目标价从178美元上调至199美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130402864","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130402864?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 14:18","pubTimestamp":1762409916,"startTime":"0","endTime":"0","summary":"查尔斯河实验室国际公司：Baird 将评级上调至“跑赢大盘”；目标价从178美元上调至199美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0757428866.USD","BK4585","LU0390134368.USD","BK4530","IE00BFMHRM44.USD","LU1815336091.USD","BK4121","CRL"],"gpt_icon":0},{"id":"1103736225","title":"查尔斯河高管表示，预计2025年制造收入将在有机基础上持平至略微下降，较之前的预计基本持平有所调整","url":"https://stock-news.laohu8.com/highlight/detail?id=1103736225","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103736225?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:23","pubTimestamp":1762352595,"startTime":"0","endTime":"0","summary":"查尔斯河高管表示，预计2025年制造收入将在有机基础上持平至略微下降，较之前的预计基本持平有所调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BK4588","LU0390134368.USD","LU0757428866.USD","BK4121","BK4585","CRL","BK4530","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"1134454671","title":"查尔斯河高管表示，尚未受到NIH预算不确定性或政府停摆的重大影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1134454671","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134454671?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:13","pubTimestamp":1762352000,"startTime":"0","endTime":"0","summary":"查尔斯河高管表示，尚未受到NIH预算不确定性或政府停摆的重大影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU0757428866.USD","LU0390134368.USD","CRL","IE00BFMHRM44.USD","LU1815336091.USD","BK4121","BK4530"],"gpt_icon":0},{"id":"1190615578","title":"查尔斯河高管表示，许多全球生物制药客户似乎已在重组工作中取得进展，生物科技融资环境在第三季度表现出改善迹象","url":"https://stock-news.laohu8.com/highlight/detail?id=1190615578","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190615578?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:11","pubTimestamp":1762351874,"startTime":"0","endTime":"0","summary":"查尔斯河高管表示，许多全球生物制药客户似乎已在重组工作中取得进展，生物科技融资环境在第三季度表现出改善迹象","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4530","LU1815336091.USD","BK4585","LU0757428866.USD","CRL","BK4121","BK4588","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"1166113766","title":"查尔斯河实验室高管表示将努力在2026年中期前完成潜在的资产剥离","url":"https://stock-news.laohu8.com/highlight/detail?id=1166113766","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166113766?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 22:09","pubTimestamp":1762351755,"startTime":"0","endTime":"0","summary":"查尔斯河实验室高管表示将努力在2026年中期前完成潜在的资产剥离","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4121","BK4530","LU1815336091.USD","LU0757428866.USD","IE00BFMHRM44.USD","BK4585","CRL","BK4588"],"gpt_icon":0},{"id":"2581733057","title":"查尔斯河公司计划出售表现不佳的资产，加大成本削减力度","url":"https://stock-news.laohu8.com/highlight/detail?id=2581733057","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581733057?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 21:55","pubTimestamp":1762350911,"startTime":"0","endTime":"0","summary":"更新版 2-查尔斯河公司计划出售表现不佳的资产，加大成本削减力度第 2 段增加股份，第 4、5 段增加分析师评论，第 10、11 段增加电话会议评论Puyaan Singh. 路透11月5日 - 合同药品开发商查尔斯河实验室公司周三宣布，计划出售一些表现不佳或非核心资产，以提高利润。查尔斯河公司也有合同制造业务，该公司公布的季度调整后利润为每股2.43美元，预期为每股2.34美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nL4T3WH1C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","BK4530","BK4121","LU0390134368.USD","IE00BFMHRM44.USD","BK4588","CRL","BK4585","LU0757428866.USD"],"gpt_icon":0},{"id":"1148653270","title":"查尔斯河实验室国际公司 - 2026年前每年额外节省7000万美元的举措","url":"https://stock-news.laohu8.com/highlight/detail?id=1148653270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148653270?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 20:04","pubTimestamp":1762344260,"startTime":"0","endTime":"0","summary":"查尔斯河实验室国际公司 - 2026年前每年额外节省7000万美元的举措","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","BK4588","LU0390134368.USD","BK4121","LU0757428866.USD","BK4585","CRL","LU1815336091.USD","IE00BFMHRM44.USD"],"gpt_icon":0},{"id":"1152229814","title":"查尔斯河实验室国际公司：预计将出售部分表现不佳或非核心业务","url":"https://stock-news.laohu8.com/highlight/detail?id=1152229814","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152229814?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 20:02","pubTimestamp":1762344133,"startTime":"0","endTime":"0","summary":"查尔斯河实验室国际公司：预计将出售部分表现不佳或非核心业务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BFMHRM44.USD","BK4530","BK4121","BK4585","LU0390134368.USD","LU1815336091.USD","LU0757428866.USD","CRL"],"gpt_icon":0},{"id":"1134406275","title":"Lisata Therapeutics 强调 Certepetide 作为抗体药物偶联物组合的积极前临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1134406275","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134406275?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 05:01","pubTimestamp":1762290074,"startTime":"0","endTime":"0","summary":"Lisata Therapeutics 强调 Certepetide 作为抗体药物偶联物组合的积极前临床数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LSTA","BK4007","BK4530","CTLT","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2580623222","title":"诺和诺德工厂出纰漏，再生元遭发CRL","url":"https://stock-news.laohu8.com/highlight/detail?id=2580623222","media":"药渡","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580623222?lang=zh_cn&edition=fundamental","pubTime":"2025-11-03 07:30","pubTimestamp":1762126243,"startTime":"0","endTime":"0","summary":"近日，FDA向再生元发出了另一封完整回复函，拒绝批准其预填充注射器版本的HD Eylea的补充上市申请。原因是其制造商—诺和诺德旗下一家名为的Indiana工厂存在未解决的问题。Catalent是这次负责HD EyleasBLA的灌装工序的CDMO，在2024年12月被诺和诺德以165亿美元收购后归入旗下。在2025年7月，FDA对Catalent的Indiana工厂进行了一次常规现场检查，其中发现多项“未解决的缺陷”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103073825a6dc6416&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103073825a6dc6416&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756325.SGD","BK4121","IE00BKVL7J92.USD","LU1093756168.USD","NVO","CRL","LU0757428866.USD","LU1815336091.USD","IE00BFMHRM44.USD","IE00BZ1G4Q59.USD","BK4530","BK4007","BK4532","BK4585","BK4599","LU0154236417.USD","LU0390134368.USD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}